Publication: Serum tissue polypeptide specific antigen (TPS) in locoregional failure and distant metastasis of cervical carcinoma
Issued Date
2000-09-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-9444249817
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.83, No.9 (2000), 1011-1015
Suggested Citation
Pittayapoom Pattaranutaporn, Nantakan Ieumwananonthachai, Yaowalak Chansilpa, Mathuros Sukkasem Serum tissue polypeptide specific antigen (TPS) in locoregional failure and distant metastasis of cervical carcinoma. Journal of the Medical Association of Thailand. Vol.83, No.9 (2000), 1011-1015. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/26176
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Serum tissue polypeptide specific antigen (TPS) in locoregional failure and distant metastasis of cervical carcinoma
Other Contributor(s)
Abstract
Tissue polypeptide specific antigen (TPS) was measured by the ELISA Technique in the sera of 51 patients with locoregional failure and metastasis of squamous cell carcinoma of the cervix in order to evaluate the serum level of TPS in known cases of metastasis and recurrence. There were 32 cases of local residual or recurrent disease and 19 cases of distant metastasis, including lymph nodes (paraaortic and supraclavicular lymph node) and visceral metastasis. The range of TPS levels in the locoregional failure group were 38.2 - 355.2 μ/l with a mean of 312.5 and 35.7 - 4822 μ/l with a mean of 833.36 μ/l in the metastatic group. With the cut-off value of 90 μ/l, the rates of TPS elevation were 27 in 32 cases (84.37%) of the loco-regional failure group and 16 in 19 cases (84.21%) of the metastatic group. Among the metastatic group, the mean of TPS level in visceral metastasis was much higher than the group of lymph node metastasis (1518.4 μ/l vs 215.1 μ/l). TPS level might be used as the follow-up guide for prediction of locoregional failure and metastasis in squamous cell carcinoma of the cervix after the completion of the treatment. In patients with a significantly high level of serum TPS, the distant metastases or local recurrence should be searched for. However, a prospective study of TPS levels in cervical cancer patients after completion of treatment should be done in order to evaluate the sensitivity and specificity of this tumor marker.